Module 5: Mantle Cell Lymphoma and Indolent Non-Hodgkin Lymphoma (iNHL)

Activity Overview

This educational activity is an archive of the live conference held from February 26, 2026, through February 28, 2026.

Target Audience 

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.

Learning Objectives

Upon participation in this activity, learners will be better able to:

• Evaluate recent clinical trial results on approved and emerging therapeutic approaches for patients with hematologic disorders
• Interpret the latest guidelines and evidence for the use of biomarker-driven strategies to stratify risk and select appropriate therapies for patients with hematologic disorders

Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource^®.